查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1414303

2024 年免疫诊断全球市场报告

Immunodiagnostics Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，免疫诊断市场规模一直强劲成长。将从2023年的213亿美元成长到2024年的229亿美元，复合年增长率为7.5%。过去一段时间的扩张归因于感染疾病的增加、自体自体免疫疾病的增加、癌症诊断和监测、感染疾病的全球化以及公共卫生努力和筛检计画的实施。

免疫诊断市场规模预计在未来几年将强劲成长。到 2028 年，将以 7.8% 的年复合成长率（CAGR）增长至 309 亿美元。预测期内的预期增长是由大流行病防范和应对、个性化医疗和生物标誌物发现的进步、新兴市场医疗保健基础设施的扩展、与实验室资讯系统的整合以及慢性病负担的增加所推动的。预测期内预计的主要趋势包括多重技术的采用、即时检测 (POCT) 的出现、生物标誌物发现和个人化医疗的进步、数位免疫诊断的兴起以及向液体活体组织切片的转变。提及。

在可预见的未来，感染疾病患者的预期增加可能会推动免疫诊断市场的成长。感染疾病的特征是病毒、细菌、真菌和寄生虫等病菌在个体之间传播，可以透过检测血液样本中是否有病毒的免疫诊断分析来识别。免疫诊断市场预计将从这一趋势中受益匪浅。例如，根据澳洲健康与福利研究所2022年7月发布的报告，2021年澳洲报告了超过471,000例COVID-19病例，其中约80,000例披衣菌感染病例、6,000例病例和37,000例曲状桿菌病例。疾病。因此，感染疾病的增加是推动免疫诊断市场成长的关键因素。

医疗保健支出的增加预计将有助于免疫诊断市场的扩大。卫生支出反映了卫生系统和经济体中与健康相关的商品和服务的总支出，在支持免疫诊断的发展和可及性方面发挥着至关重要的作用。 2022 年 11 月，加拿大健康资讯研究所报告称，医疗支出继 2021 年增长 7.6% 后，2022 年将成长 0.8%，达到 3,310 亿美元。医疗保健支出的快速成长正在推动免疫诊断市场的成长。

2023年免疫诊断市场最大的地区是北美。免疫诊断市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美以及中东和非洲。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球免疫诊断市场的驱动与抑制因素
    • 市场驱动因素
    • 市场抑制因素
  • 2018-2023年全球免疫诊断市场规模表现与成长
  • 全球免疫诊断市场规模及成长预测，2023-2028、2033

第六章市场区隔

  • 全球免疫诊断市场，依产品、性能及预测细分，2018-2023、2023-2028、2033
  • 试剂及耗材
  • 装置
  • 软体和服务
  • 全球免疫诊断市场，依技术、效能和预测细分，2018-2023、2023-2028、2033
  • 酵素免疫分析法
  • 化学冷光免疫检测
  • 萤光免疫分析
  • 免疫测量
  • 快速测试
  • 其他技术
  • 全球免疫诊断市场，按应用、效能和预测细分，2018-2023、2023-2028、2033
  • 感染疾病
  • 肿瘤学和内分泌学
  • 骨骼和矿物质疾病
  • 自体免疫疾病
  • 心臟生物标记
  • 药物监测
  • 其他用途
  • 全球免疫诊断市场，按最终用户细分，实际和预测，2018-2023、2023-2028、2033
  • 医院
  • 诊所
  • 诊断实验室
  • 学术研究所
  • 其他最终用户

第 7 章 区域与国家分析

  • 全球免疫诊断市场，按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球免疫诊断市场，依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 免疫诊断市场竞争形势
  • 免疫诊断市场公司概况
    • Abbott Laboratories
    • Arkray Inc.
    • bioMerieux Inc.
    • Immunodiagnostic Systems Holdings Plc（IDS）
    • Bio-Rad Laboratories Inc.

第31章竞争基准化分析

第 32 章竞争对手仪表板

第三十三章 重大併购

第34章 未来前景与潜力分析

第35章附录

简介目录
Product Code: r11813

“Immunodiagnostics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunodiagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunodiagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The immunodiagnostics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Reagents And Consumables; Instruments; Software And Services
  • 2) By Technology: Enzyme-Linked Immunosorbent Assay; Chemiluminescence Immunoassay; Fluorescent Immunoassay; Radioimmunoassay; Rapid Test; Other Technologies
  • 3) By Application: Infectious Diseases; Oncology And Endocrinology; Bone And Mineral Diseases; Autoimmunity Disorders; Cardiac Biomarkers; Drug Monitoring; Other Applications
  • 4) By End User: Hospitals; Clinics; Diagnostic Laboratories; Academic And Research Institutes; Other End Users
  • Companies Mentioned: Abbott Laboratories; Arkray Inc.; bioMerieux Inc.; Immunodiagnostic Systems Holdings Plc (IDS); Bio-Rad Laboratories Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Immunodiagnostics is a diagnostic approach that relies primarily on the antigen-antibody response for detecting serum insulin. These tests are employed to identify antibodies and parasite antigens.

The principal products in the field of immunodiagnostics include reagents and consumables, instruments and software, and services. Reagents are substances used to initiate chemical reactions with other substances to detect the presence of specific substances, while consumables refer to traceable items utilized in the execution of analysis techniques. The technologies involved encompass enzyme-linked immunosorbent assay, chemiluminescence immunoassay, fluorescent immunoassay, radioimmunoassay, rapid tests, and others. These technologies find applications in various medical fields such as infectious diseases, oncology, endocrinology, bone and mineral diseases, autoimmunity disorders, cardiac biomarkers, drug monitoring, and more. The end-users of immunodiagnostics include hospitals, clinics, diagnostic laboratories, academic and research institutes, among others.

The immunodiagnostics market research report is one of a series of new reports from The Business Research Company that provides immunodiagnostics market statistics, including immunodiagnostics industry global market size, regional shares, competitors with immunodiagnostics market share, detailed immunodiagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the immunodiagnostics industry. This immunodiagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The immunodiagnostics market size has grown strongly in recent years. It will grow from $21.3 billion in 2023 to $22.9 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The expansion observed in the historical period can be attributed to the increasing incidence of infectious diseases, the rise in autoimmune diseases, the diagnosis and monitoring of cancer, the globalization of infectious diseases, and the implementation of public health initiatives and screening programs.

The immunodiagnostics market size is expected to see strong growth in the next few years. It will grow to $30.9 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The anticipated growth in the forecast period can be attributed to preparedness and response to pandemics, advancements in personalized medicine and biomarker discovery, the expansion of healthcare infrastructure in emerging markets, integration with laboratory information systems, and the increasing burden of chronic diseases. Key trends expected in the forecast period involve the adoption of multiplexing technologies, the emergence of point-of-care testing (POCT), advancements in biomarker discovery and personalized medicine, the rise of digital immunodiagnostics, and a shift towards liquid biopsy.

The anticipated increase in the prevalence of infectious diseases is poised to drive the growth of the immunodiagnostics market in the foreseeable future. Infectious diseases, characterized by the transmission of germs such as viruses, bacteria, fungi, or parasites among individuals, can be identified using immunodiagnostic assays that detect the presence of viruses in blood samples. The immunodiagnostics market is expected to benefit significantly from this trend. For example, a report by the Australian Institute of Health and Welfare in July 2022 revealed over 471,000 reported COVID-19 cases in Australia in 2021, along with approximately 86,000 cases of chlamydia and a rise to 37,000 cases of campylobacter, a gastrointestinal illness. Thus, the increasing prevalence of infectious diseases is a major driver for the growth of the immunodiagnostics market.

The upward trajectory in healthcare expenditure is foreseen to contribute to the expansion of the immunodiagnostics market. Healthcare expenditure, reflecting the total spending on healthcare-related goods and services within a healthcare system or economy, plays a pivotal role in supporting the development and accessibility of immunodiagnostics. In November 2022, the Canadian Institute for Health Information reported a 0.8% increase in healthcare expenditure to $331 billion in 2022, following a 7.6% rise in 2021. This surge in healthcare expenditure is instrumental in propelling the growth of the immunodiagnostics market.

Technological advancement emerges as a prominent trend in the immunodiagnostics market, with major companies focusing on the development of innovative technologies to maintain their market position. Cavidi AB, a Sweden-based developer of viral load solutions, introduced Exazym in May 2021. This signal-generating technology enhances the sensitivity of conventional immunodiagnostic assays, allowing for ultra-sensitive detection levels. Cavidi Exazym is poised to enhance research, health screenings, and diagnostic testing, enabling the detection of biomarkers beyond the capabilities of existing diagnostic techniques.

Major companies in the immunodiagnostics market are increasingly forming partnerships to drive revenues. Collaborations involving medical experts, academic entities, and IT firms can significantly contribute to market expansion by fostering innovation and accelerating clinical immunodiagnostics. For example, in October 2022, Telix Pharmaceuticals Limited, an Australia-based radiopharmaceutical company, partnered with GE Healthcare, a US-based medical technology company, to combine Telix's investigational PET imaging radiotracers with GE Healthcare's immuno-diagnostic range. This collaboration aims to improve therapy selection and patient monitoring in immunotherapy trials.

In July 2021, DiaSorin S.p.A., an Italy-based biotechnology company, acquired Luminex Corporation for $1.8 billion. This strategic move granted DiaSorin access to Luminex's multiplexing technology and expanded its portfolio, reinforcing its position in the United States. Luminex Corporation, based in the US, is known for developing, manufacturing, and selling proprietary biological testing technologies and products across life sciences, transplant research, and immunodiagnostics.

Major companies operating in the immunodiagnostics market report are Abbott Laboratories, Arkray Inc., bioMerieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, PerkinElmer Inc., Merck KGaA, Becton Dickinson and Company, Grifols S.A., Ortho Clinical Diagnostics, Beckman Coulter Inc., Bio-Techne Corporation, Creative Diagnostics, Fujirebio Holdings Inc., Gold Standard Diagnostics Corp., Hologic Inc., Luminex Corporation, Myriad Genetics Inc., Natera Inc., OraSure Technologies Inc., Quidel Corporation

North America was the largest region in the immunodiagnostics market in 2023. The regions covered in the immunodiagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunodiagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunodiagnostics market consists of revenues earned by entities by providing agglutination, nephelometry, immunoprecipitation, and radial immunodiffusion test services. The market value includes the value of related goods sold by the service provider or included within the service offering. The immunodiagnostics market also includes sales of anti-streptolysin-O latex, infectious mononucleosis slide, rheumatoid factor, and syphilis serology reagent. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Immunodiagnostics Market Characteristics

3. Immunodiagnostics Market Trends And Strategies

4. Immunodiagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Immunodiagnostics Market Size and Growth

  • 5.1. Global Immunodiagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Immunodiagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Immunodiagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Immunodiagnostics Market Segmentation

  • 6.1. Global Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Reagents And Consumables
  • Instruments
  • Software And Services
  • 6.2. Global Immunodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Enzyme-Linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Fluorescent Immunoassay
  • Radioimmunoassay
  • Rapid Test
  • Other Technologies
  • 6.3. Global Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Infectious Diseases
  • Oncology And Endocrinology
  • Bone And Mineral Diseases
  • Autoimmunity Disorders
  • Cardiac Biomarkers
  • Drug Monitoring
  • Other Applications
  • 6.4. Global Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Academic And Research Institutes
  • Other End Users

7. Immunodiagnostics Market Regional And Country Analysis

  • 7.1. Global Immunodiagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Immunodiagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Immunodiagnostics Market

  • 8.1. Asia-Pacific Immunodiagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Immunodiagnostics Market

  • 9.1. China Immunodiagnostics Market Overview
  • 9.2. China Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Immunodiagnostics Market

  • 10.1. India Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Immunodiagnostics Market

  • 11.1. Japan Immunodiagnostics Market Overview
  • 11.2. Japan Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Immunodiagnostics Market

  • 12.1. Australia Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Immunodiagnostics Market

  • 13.1. Indonesia Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Immunodiagnostics Market

  • 14.1. South Korea Immunodiagnostics Market Overview
  • 14.2. South Korea Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Immunodiagnostics Market

  • 15.1. Western Europe Immunodiagnostics Market Overview
  • 15.2. Western Europe Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Immunodiagnostics Market

  • 16.1. UK Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Immunodiagnostics Market

  • 17.1. Germany Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Immunodiagnostics Market

  • 18.1. France Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Immunodiagnostics Market

  • 19.1. Italy Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Immunodiagnostics Market

  • 20.1. Spain Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Immunodiagnostics Market

  • 21.1. Eastern Europe Immunodiagnostics Market Overview
  • 21.2. Eastern Europe Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Immunodiagnostics Market

  • 22.1. Russia Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Immunodiagnostics Market

  • 23.1. North America Immunodiagnostics Market Overview
  • 23.2. North America Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Immunodiagnostics Market

  • 24.1. USA Immunodiagnostics Market Overview
  • 24.2. USA Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Immunodiagnostics Market

  • 25.1. Canada Immunodiagnostics Market Overview
  • 25.2. Canada Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Immunodiagnostics Market

  • 26.1. South America Immunodiagnostics Market Overview
  • 26.2. South America Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Immunodiagnostics Market

  • 27.1. Brazil Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Immunodiagnostics Market

  • 28.1. Middle East Immunodiagnostics Market Overview
  • 28.2. Middle East Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Immunodiagnostics Market

  • 29.1. Africa Immunodiagnostics Market Overview
  • 29.2. Africa Immunodiagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Immunodiagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Immunodiagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Immunodiagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Immunodiagnostics Market Competitive Landscape
  • 30.2. Immunodiagnostics Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Arkray Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. bioMerieux Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Immunodiagnostic Systems Holdings Plc (IDS)
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bio-Rad Laboratories Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Immunodiagnostics Market Competitive Benchmarking

32. Global Immunodiagnostics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Immunodiagnostics Market

34. Immunodiagnostics Market Future Outlook and Potential Analysis

  • 34.1 Immunodiagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Immunodiagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Immunodiagnostics Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer